Cite

HARVARD Citation

    Brown, M. et al. (2021). Clinical chimeric antigen receptor T‐cell therapy: a new and promising treatment modality for glioblastoma. Clinical & translational immunology. 10 (8), p. n/a. [Online]. 
  
Back to record